Litigation and regulatory developments related to PFAS continue to expand, exposing an increasing number of industries and companies to various risks Companies should assess the potential impact of ...

With evolving regulations and emerging risks—including tariffs, DEI-related controversies, and cybersecurity concerns—some public companies are refining their approach to assessing and updating risk ...

CHICAGO, March 30 (Reuters) - The highest dose of an experimental drug developed by Eli Lilly (LLY.N), opens new tab significantly reduced levels of a genetically inherited risk factor for heart ...

Cap-weighted benchmarks incorporate no explicit objective to capture exposure to those risk factors that have been documented in the academic literature to offer a long-term reward. Deviations from ...

In a new extensive systematic review, researchers identified 17 modifiable risk factors that are shared by stroke, dementia, and late-life depression. Modifying any one of them can reduce your risk of ...